Anydana A FirmwareOperating system · Sooil

CVE-2020-27266

MEDIUM · 6.5 CVSS v3.1 Published 2021-01-19
Fix available
A fix is available. Upgrade to 3.0 or later.
See remediation →
70/100
Remediation priority · Elevated
No privileges Zero-click

Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.

NVD · unedited
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.

Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.

dbcve analysis · moderate confidence

A client-side authentication bypass vulnerability in the AnyDana-i and AnyDana-A mobile applications and Diabecare RS insulin pump allows physically proximate attackers to bypass user authentication via Bluetooth Low Energy. The application relies on client-side controls that can be circumvented, enabling unauthorized access to insulin delivery functions.

MitigationImplement server-side authentication and proper BLE pairing with strong, unique session tokens. The insulin pump firmware and mobile applications both require updates to enforce server-validated authentication and prevent client-side bypass.

Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.

Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.

NVD · CPE data
Anydana A FirmwareOperating system
Affected:< 3.0
Anydana I FirmwareOperating system
Affected:< 3.0
Diabecare Rs FirmwareOperating system
Affected:< 3.0

CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.

From the vector
Attack vector
Adjacent
Complexity
Low
Privileges
None
User interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
None
Availability
None

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.

dbcve checks

Work through these to decide whether this CVE applies to you.

  1. Identify device model and firmware version
    Connect to the insulin pump (AnyDana-A, AnyDana-I, or Diabecare RS) via its management software or check the device display/menu for firmware version information. Alternatively, use BLE tools to query the device's GATT services for firmware version characteristics.
    Affected if The firmware version is below 3.0 on Sooil Anydana A, Anydana I, or Diabecare RS devices.
  2. Verify BLE pairing security configuration
    Use a BLE scanner or analyzer tool to examine the pairing process between the mobile application and the pump. Check whether the connection requires PIN/key exchange or relies solely on client-side validation without cryptographic verification.
    Affected if BLE pairing allows unauthenticated access or relies purely on client-side checks without strong session tokens.
  3. Inspect mobile app authentication flow
    Review the mobile application (AnyDana-i or AnyDana-A) network traffic and local storage to determine whether authentication tokens are validated server-side or checked locally within the app only.
    Affected if The application performs authentication locally without server-side verification of credentials or session validity.
  4. Check for authorized insulin delivery commands
    Test whether BLE commands to modify insulin delivery settings (basal rates, bolus amounts) can be sent without a valid server-authenticated session. Use a BLE testing tool to inject delivery commands and observe if they execute without proper server validation.
    Affected if Insulin delivery functions are accessible via BLE without server-validated authentication.

A user is affected if their Sooil Anydana A, Anydana I, or Diabecare RS insulin pump runs firmware version below 3.0 and relies on client-side BLE authentication that can be bypassed.

Generated from the published advisory. Verify against your own configuration.

Check your environment

Paste your version and any relevant configuration and it will be compared against the affected criteria above. Do not include secrets or credentials.

AI-assisted, checked against the advisory. Informational, not a guarantee.

Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.

From vendor data
Upgrade available Upgrade to 3.0 or later
Fixed in 3.0
Interim mitigation

Implement server-side authentication and proper BLE pairing with strong, unique session tokens. The insulin pump firmware and mobile applications both require updates to enforce server-validated authentication and prevent client-side bypass.

Fix this in Anydana A Firmware Scoped from the published advisory
  • Consultation8.0 h
  • Implementation40.0 h
  • Testing24.0 h
  • Review / QA12.0 h
84.0 hours of engineering $14,560
Get the upgrade done

An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $23,296.

Scan for this in your stack

Free · runs locally
dbcve dependency scanner

Check whether your project pulls in CVE-2020-27266 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.

References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.

Primary sources

Practitioner notes

Contributed

Peer-ranked notes from engineers who’ve handled CVE-2020-27266 in production — separate from our analysis above.

No notes yet

Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.

What this is

A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.

What belongs here
  • Verified mitigations, workarounds, and config changes
  • Version or environment caveats, and links to real fixes
  • No weaponised exploit code, or anything meant to cause harm
  • No spam, self-promotion, credentials, or personal data